메뉴 건너뛰기




Volumn 33, Issue 4, 2008, Pages 313-327

Update on the diagnosis and therapy of distant metastases of differentiated thyroid carcinoma

Author keywords

Neoplasm metastasis, therapy; Radiotherapy; Thyroid neoplasms

Indexed keywords

B RAF KINASE; BEVACIZUMAB; CETUXIMAB; CYCLOOXYGENASE 2 INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIRUBICIN; FLUOROURACIL; FOLINIC ACID; HISTONE DEACETYLASE INHIBITOR; IMATINIB; IRINOTECAN; LITHIUM; MITOGEN ACTIVATED PROTEIN KINASE; PLATELET DERIVED GROWTH FACTOR; RADIOACTIVE IODINE; RAS PROTEIN; RETINOID X RECEPTOR; RETINOL; THALIDOMIDE; THYROTROPIN; VASCULOTROPIN; ANTINEOPLASTIC AGENT;

EID: 60849100251     PISSN: 03911977     EISSN: 18271634     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (14)

References (99)
  • 1
    • 33646442046 scopus 로고    scopus 로고
    • Increasing incidence of thyroid cancer in the United States, 1973-2002
    • Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006;295:2164-7.
    • (2006) JAMA , vol.295 , pp. 2164-2167
    • Davies, L.1    Welch, H.G.2
  • 2
    • 0032535770 scopus 로고    scopus 로고
    • A National Cancer Data Base report on 53 856 cases of thyroid carcinoma treated in the U.S., 1985-1995
    • Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53 856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer 1998;83:2638-48.
    • (1998) Cancer , vol.83 , pp. 2638-2648
    • Hundahl, S.A.1    Fleming, I.D.2    Fremgen, A.M.3    Menck, H.R.4
  • 3
    • 0032576677 scopus 로고    scopus 로고
    • Papillary and follicular thyroid carcinoma
    • Schlumberger MJ. Papillary and follicular thyroid carcinoma. N Engl J Med 1998;338:297-306.
    • (1998) N Engl J Med , vol.338 , pp. 297-306
    • Schlumberger, M.J.1
  • 5
    • 0027429811 scopus 로고
    • Different features of pulmonary metastases in differentiated thyroid cancer: Natural history and multivariate statistical analysis of prognostic variables
    • Casara D, Rubello D, Saladini G, Masarotto G, Favero A, Girelli ME et al. Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables. J Nucl Med 1993,34:1626-31.
    • (1993) J Nucl Med , vol.34 , pp. 1626-1631
    • Casara, D.1    Rubello, D.2    Saladini, G.3    Masarotto, G.4    Favero, A.5    Girelli, M.E.6
  • 6
    • 0033310359 scopus 로고    scopus 로고
    • Immediate causes of death in thyroid carcinoma clinicopathological analysis of 161 fatal cases
    • Kitamura Y, Shimizu K, Nagahama M, Sugino K, Ozaki O, Mimura T et al. Immediate causes of death in thyroid carcinoma: clinicopathological analysis of 161 fatal cases. J Clin Endocrinol Metab 1999;84:4043-9.
    • (1999) J Clin Endocrinol Metab , vol.84 , pp. 4043-4049
    • Kitamura, Y.1    Shimizu, K.2    Nagahama, M.3    Sugino, K.4    Ozaki, O.5    Mimura, T.6
  • 7
    • 0033401991 scopus 로고    scopus 로고
    • Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases
    • Lin JD, Huang MJ, Juang JH, Chao TC, Huang BY, Chen KW et al. Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases. Thyroid 1999;9:1227-35.
    • (1999) Thyroid , vol.9 , pp. 1227-1235
    • Lin, J.D.1    Huang, M.J.2    Juang, J.H.3    Chao, T.C.4    Huang, B.Y.5    Chen, K.W.6
  • 8
    • 0035016937 scopus 로고    scopus 로고
    • Cause of death in patients with well-differentiated thyroid carcinoma
    • Beasley NJ, Walfish PG, Witterick I, Freeman JL. Cause of death in patients with well-differentiated thyroid carcinoma. Laryngoscope 2001;111:989-91.
    • (2001) Laryngoscope , vol.111 , pp. 989-991
    • Beasley, N.J.1    Walfish, P.G.2    Witterick, I.3    Freeman, J.L.4
  • 9
    • 33745775455 scopus 로고    scopus 로고
    • Differentiated thyroid carcinoma how to improve the long-term results? Twenty-five-year outcomes of 850 patients
    • Melliere D, Hindie E, Becquemin JP, Desgranges P, Allaire E, Geachan E. Differentiated thyroid carcinoma how to improve the long-term results? Twenty-five-year outcomes of 850 patients. Bull Acad Natl Med 2006;190:89-106.
    • (2006) Bull Acad Natl Med , vol.190 , pp. 89-106
    • Melliere, D.1    Hindie, E.2    Becquemin, J.P.3    Desgranges, P.4    Allaire, E.5    Geachan, E.6
  • 10
    • 33645465719 scopus 로고    scopus 로고
    • Management guidelines for patients with thyroid nodules and differentiated thyroid cancer
    • Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006;16:109-42.
    • (2006) Thyroid , vol.16 , pp. 109-142
    • Cooper, D.S.1    Doherty, G.M.2    Haugen, B.R.3    Kloos, R.T.4    Lee, S.L.5    Mandel, S.J.6
  • 13
    • 33747642244 scopus 로고    scopus 로고
    • Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: Benefits and limits of radioiodine therapy
    • Durante C, Haddy N, Baudin E, Leboulleux S, Hartl D, Travagli JP et al. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab 2006;91:2892-9.
    • (2006) J Clin Endocrinol Metab , vol.91 , pp. 2892-2899
    • Durante, C.1    Haddy, N.2    Baudin, E.3    Leboulleux, S.4    Hartl, D.5    Travagli, J.P.6
  • 14
    • 29144520426 scopus 로고    scopus 로고
    • Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: A qualitative review
    • Jarzab B, Handkiewicz-Junak D, Wloch J. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review. Endocr Relat Cancer 2005;12:773-803.
    • (2005) Endocr Relat Cancer , vol.12 , pp. 773-803
    • Jarzab, B.1    Handkiewicz-Junak, D.2    Wloch, J.3
  • 15
    • 0027421309 scopus 로고
    • Prognostic importance of various clinicopathological features in papillary thyroid carcinoma
    • Akslen LA, Myking AO, Salvesen H, Varhaug JE. Prognostic importance of various clinicopathological features in papillary thyroid carcinoma. Eur J Cancer 1992;29A:44-51.
    • (1992) Eur J Cancer , vol.29 A , pp. 44-51
    • Akslen, L.A.1    Myking, A.O.2    Salvesen, H.3    Varhaug, J.E.4
  • 17
    • 0031440829 scopus 로고    scopus 로고
    • The role of radioactive iodine in the treatment of advanced differentiated thyroid carcinoma
    • Pelikan DM, Lion HL, Hermans J, Goslings BM. The role of radioactive iodine in the treatment of advanced differentiated thyroid carcinoma. Clin Endocrinol (Oxf) 1997;47:713-20. (Pubitemid 28046560)
    • (1997) Clinical Endocrinology , vol.47 , Issue.6 , pp. 713-720
    • Pelikan, D.M.V.1    Lion, H.L.2    Hermans, J.3    Goslings, B.M.4
  • 18
    • 0031798686 scopus 로고    scopus 로고
    • Clinical forms of presentation and evolution of diffuse sclerosing variant of papillary carcinoma and insular variant of follicular carcinoma of the thyroid
    • Albareda M, Puig-Domingo M, Wengrowicz S, Soldevila J, Matias-Guiu X, Caballero A et al. Clinical forms of presentation and evolution of diffuse sclerosing variant of papillary carcinoma and insular variant of follicular carcinoma of the thyroid. Thyroid 1998;8:385-91.
    • (1998) Thyroid , vol.8 , pp. 385-391
    • Albareda, M.1    Puig-Domingo, M.2    Wengrowicz, S.3    Soldevila, J.4    Matias-Guiu, X.5    Caballero, A.6
  • 19
    • 0019522882 scopus 로고
    • Papillary thyroid carcinoma: A 10 year follow-up report of the impact of therapy in 576 patients
    • Mazzaferri EL, Young RL. Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. Am J Med 1981;70:511-8.
    • (1981) Am J Med , vol.70 , pp. 511-518
    • Mazzaferri, E.L.1    Young, R.L.2
  • 21
    • 26244467655 scopus 로고    scopus 로고
    • Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis
    • Leboulleux S, Rubino C, Baudin E, Caillou B, Hartl DM, Bidart JM et al. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab 2005;90:5723-9.
    • (2005) J Clin Endocrinol Metab , vol.90 , pp. 5723-5729
    • Leboulleux, S.1    Rubino, C.2    Baudin, E.3    Caillou, B.4    Hartl, D.M.5    Bidart, J.M.6
  • 22
    • 85047681191 scopus 로고    scopus 로고
    • Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer
    • Mazzaferri EL, Kloos RT. Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 2001;86:1447-63.
    • (2001) J Clin Endocrinol Metab , vol.86 , pp. 1447-1463
    • Mazzaferri, E.L.1    Kloos, R.T.2
  • 23
    • 8744240542 scopus 로고    scopus 로고
    • Prognostic factors associated with the survival of patients developing locoregional recurrences of differentiated thyroid carcinomas
    • Rouxel A, Hejblum G, Bernier MO, Boëlle PY, Ménégaux F, Mansour G et al. Prognostic factors associated with the survival of patients developing locoregional recurrences of differentiated thyroid carcinomas. J Clin Endocrinol Metab 2004;89:5362-8.
    • (2004) J Clin Endocrinol Metab , vol.89 , pp. 5362-5368
    • Rouxel, A.1    Hejblum, G.2    Bernier, M.O.3    Boëlle, P.Y.4    Ménégaux, F.5    Mansour, G.6
  • 24
    • 0027943619 scopus 로고
    • Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer
    • Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994;97:418-28.
    • (1994) Am J Med , vol.97 , pp. 418-428
    • Mazzaferri, E.L.1    Jhiang, S.M.2
  • 25
    • 0035143839 scopus 로고    scopus 로고
    • Identifying differentially expressed genes associated with metastasis of follicular thyroid cancer by cDNA expression array
    • Chen KT, Lin JD, Chao TC, Hsueh C, Chang CA, Weng HF et al. Identifying differentially expressed genes associated with metastasis of follicular thyroid cancer by cDNA expression array. Thyroid 2001;11:41-6.
    • (2001) Thyroid , vol.11 , pp. 41-46
    • Chen, K.T.1    Lin, J.D.2    Chao, T.C.3    Hsueh, C.4    Chang, C.A.5    Weng, H.F.6
  • 27
    • 34548192281 scopus 로고    scopus 로고
    • The prevalence and prognostic value of BRAF mutation in thyroid cancer
    • Kebebew E, Weng J, Bauer J, Ranvier G, Clark OH, Duh QY et al. The prevalence and prognostic value of BRAF mutation in thyroid cancer. Ann Surg 2007;246:466-70.
    • (2007) Ann Surg , vol.246 , pp. 466-470
    • Kebebew, E.1    Weng, J.2    Bauer, J.3    Ranvier, G.4    Clark, O.H.5    Duh, Q.Y.6
  • 28
    • 42949099868 scopus 로고    scopus 로고
    • Consensus conference: Management of differentiated cancers of the thyroid vesicular structure
    • Paris
    • Consensus conference: management of differentiated cancers of the thyroid vesicular structure. Ann Endocrinol (Paris) 2007;68(Suppl 2):S53-6.
    • (2007) Ann Endocrinol , vol.68 , Issue.SUPPL. 2
  • 32
    • 0031724072 scopus 로고    scopus 로고
    • External-beam radiation therapy in the treatment of differentiated thyroid cancer
    • Brierley JD, Tsang RW. External-beam radiation therapy in the treatment of differentiated thyroid cancer. Semin Surg Oncol 1999;16:42-9.
    • (1999) Semin Surg Oncol , vol.16 , pp. 42-49
    • Brierley, J.D.1    Tsang, R.W.2
  • 33
    • 0029896016 scopus 로고    scopus 로고
    • Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy
    • Vassilopoulou-Sellin R, Schultz PN, Haynie TP. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy. Cancer 1996;78:493-501.
    • (1996) Cancer , vol.78 , pp. 493-501
    • Vassilopoulou-Sellin, R.1    Schultz, P.N.2    Haynie, T.P.3
  • 34
    • 33846490718 scopus 로고    scopus 로고
    • New therapeutic approaches for metastatic thyroid carcinoma
    • Baudin E, Schlumberger M. New therapeutic approaches for metastatic thyroid carcinoma. Lancet Oncol 2007;8:148-56.
    • (2007) Lancet Oncol , vol.8 , pp. 148-156
    • Baudin, E.1    Schlumberger, M.2
  • 37
    • 22044458191 scopus 로고    scopus 로고
    • Differentiated thyroid carcinoma with distant metastases at presentation: Prognostic factors and outcome
    • DOI 10.1111/j.1365-2265.2005.02304.x
    • Haq M, Harmer C. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome. Clin Endocrinol (Oxf) 2005;63:87-93. (Pubitemid 40966408)
    • (2005) Clinical Endocrinology , vol.63 , Issue.1 , pp. 87-93
    • Haq, M.1    Harmer, C.2
  • 39
    • 34648834395 scopus 로고    scopus 로고
    • Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis
    • Sampson E, Brierley JD, Le LW, Rotstein L, Tsang RW. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis. Cancer 2007;110:1451-6.
    • (2007) Cancer , vol.110 , pp. 1451-1456
    • Sampson, E.1    Brierley, J.D.2    Le, L.W.3    Rotstein, L.4    Tsang, R.W.5
  • 40
    • 0034040689 scopus 로고    scopus 로고
    • Differentiated thyroid cancer: Clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children's Cancer Group
    • La Quaglia MP, Black T, Holcomb GW 3rd, Sklar C, Azizkhan RG, Haase GM et al. Differentiated thyroid cancer: clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children's Cancer Group. J Pediatr Surg 2000;35:955-9.
    • (2000) J Pediatr Surg , vol.35 , pp. 955-959
    • La Quaglia, M.P.1    Black, T.2    Holcomb III, G.W.3    Sklar, C.4    Azizkhan, R.G.5    Haase, G.M.6
  • 41
    • 0031710453 scopus 로고    scopus 로고
    • Pulmonary metastases in children and adolescents with well-differentiated thyroid cancer
    • Samuel AM, Rajashekharrao B, Shah DH. Pulmonary metastases in children and adolescents with well-differentiated thyroid cancer. J Nucl Med 1998;39:1531-6.
    • (1998) J Nucl Med , vol.39 , pp. 1531-1536
    • Samuel, A.M.1    Rajashekharrao, B.2    Shah, D.H.3
  • 43
    • 0027933714 scopus 로고
    • Outcome of 309 patients with metastatic thyroid carcinoma treated with radioiodine
    • Pacini F, Cetani F, Miccoli P, Mancusi F, Ceccarelli C, Lippi F et al. Outcome of 309 patients with metastatic thyroid carcinoma treated with radioiodine. World J Surg 1994;18:600-4.
    • (1994) World J Surg , vol.18 , pp. 600-604
    • Pacini, F.1    Cetani, F.2    Miccoli, P.3    Mancusi, F.4    Ceccarelli, C.5    Lippi, F.6
  • 44
    • 17744368257 scopus 로고    scopus 로고
    • Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas
    • Bernier MO, Leenhardt L, Hoang C, Aurengo A, Mary JY, Menegaux F et al. Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas. J Clin Endocrinol Metab 2001;86:1568-73.
    • (2001) J Clin Endocrinol Metab , vol.86 , pp. 1568-1573
    • Bernier, M.O.1    Leenhardt, L.2    Hoang, C.3    Aurengo, A.4    Mary, J.Y.5    Menegaux, F.6
  • 45
    • 0022860216 scopus 로고
    • Surgical treatment of distant metastases in differentiated thyroid cancer: Indication and results
    • Niederle B, Roka R, Schemper M, Fritsch A, Weissel M, Ramach W. Surgical treatment of distant metastases in differentiated thyroid cancer: indication and results. Surgery 1986;100:1088-97.
    • (1986) Surgery , vol.100 , pp. 1088-1097
    • Niederle, B.1    Roka, R.2    Schemper, M.3    Fritsch, A.4    Weissel, M.5    Ramach, W.6
  • 46
    • 0034085346 scopus 로고    scopus 로고
    • Bone metastases from thyroid carcinoma: Clinical characteristics and prognostic variables in one hundred forty-six patients
    • Pittas AG, Adler M, Fazzari M, Tickoo S, Rosai J, Larson SM et al. Bone metastases from thyroid carcinoma: clinical characteristics and prognostic variables in one hundred forty-six patients. Thyroid 2000;10:261-8.
    • (2000) Thyroid , vol.10 , pp. 261-268
    • Pittas, A.G.1    Adler, M.2    Fazzari, M.3    Tickoo, S.4    Rosai, J.5    Larson, S.M.6
  • 47
    • 0036226649 scopus 로고    scopus 로고
    • Long-term follow-up of patients with bone metastases from differentiated thyroid carcinoma surgery or conventional therapy?
    • Oxf
    • Zettinig G, Fueger BJ, Passier C, Kaserer K, Pirich C, Dudczak R et al. Long-term follow-up of patients with bone metastases from differentiated thyroid carcinoma surgery or conventional therapy? Clin Endocrinol (Oxf) 2002;56:377-82.
    • (2002) Clin Endocrinol , vol.56 , pp. 377-382
    • Zettinig, G.1    Fueger, B.J.2    Passier, C.3    Kaserer, K.4    Pirich, C.5    Dudczak, R.6
  • 48
    • 41149095035 scopus 로고    scopus 로고
    • Measuring thyroglobulin and thyroglobulin autoantibody in patients with differentiated thyroid cancer
    • Spencer CA, Lopresti JS. Measuring thyroglobulin and thyroglobulin autoantibody in patients with differentiated thyroid cancer. Nat Clin Pract Endocrinol Metab 2008;4:223-33.
    • (2008) Nat Clin Pract Endocrinol Metab , vol.4 , pp. 223-233
    • Spencer, C.A.1    Lopresti, J.S.2
  • 51
    • 0023697542 scopus 로고
    • Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest X-rays
    • Schlumberger M, Arcangioli O, Piekarski JD, Tubiana M, Parmentier C. Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest X-rays. J Nucl Med 1988;29:1790-4.
    • (1988) J Nucl Med , vol.29 , pp. 1790-1794
    • Schlumberger, M.1    Arcangioli, O.2    Piekarski, J.D.3    Tubiana, M.4    Parmentier, C.5
  • 52
    • 0033457279 scopus 로고    scopus 로고
    • Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: Results of a multicentre study
    • Grünwald F, Kälicke T, Feine U, Lietzenmayer R, Scheidhauer K, Dietlein M et al. Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study. Eur J Nucl Med 1999;26:1547-52.
    • (1999) Eur J Nucl Med , vol.26 , pp. 1547-1552
    • Grünwald, F.1    Kälicke, T.2    Feine, U.3    Lietzenmayer, R.4    Scheidhauer, K.5    Dietlein, M.6
  • 53
    • 33846898006 scopus 로고    scopus 로고
    • Should "low-risk" thyroid cancer patients with residual thyroglobulin be re-treated with iodine 131?
    • Oxf
    • Hindié E, Zanotti-Fregonara P, Duron F, Keller I, Bouchard P, Devaux JY. Should "low-risk" thyroid cancer patients with residual thyroglobulin be re-treated with iodine 131? Clin Endocrinol (Oxf) 2007;66:329-34.
    • (2007) Clin Endocrinol , vol.66 , pp. 329-334
    • Hindié, E.1    Zanotti-Fregonara, P.2    Duron, F.3    Keller, I.4    Bouchard, P.5    Devaux, J.Y.6
  • 55
    • 32544437659 scopus 로고    scopus 로고
    • Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning
    • Robbins RJ, Wan Q, Grewal RK, Reibke R, Gonen M, Strauss HW et al. Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning. J Clin Endocrinol Metab 2006;91:498-505.
    • (2006) J Clin Endocrinol Metab , vol.91 , pp. 498-505
    • Robbins, R.J.1    Wan, Q.2    Grewal, R.K.3    Reibke, R.4    Gonen, M.5    Strauss, H.W.6
  • 57
    • 16444375322 scopus 로고    scopus 로고
    • rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: A comprehensive review
    • Luster M, Lippi F, Jarzab B, Perros P, Lassmann M, Reiners C et al. rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review. Endocr Relat Cancer 2005; 12:49-64.
    • (2005) Endocr Relat Cancer , vol.12 , pp. 49-64
    • Luster, M.1    Lippi, F.2    Jarzab, B.3    Perros, P.4    Lassmann, M.5    Reiners, C.6
  • 59
    • 37249026112 scopus 로고    scopus 로고
    • Papillary thyroid carcinoma with distant metastases: Survival predictors and the importance of local control
    • DOI 10.1016/j.surg.2007.06.011, PII S0039606007003704
    • Sugitani I, Fujimoto Y, Yamamoto N. Papillary thyroid carcinoma with distant metastases: survival predictors and the importance of local control. Surgery 2008;143:35-42. (Pubitemid 350266026)
    • (2008) Surgery , vol.143 , Issue.1 , pp. 35-42
    • Sugitani, I.1    Fujimoto, Y.2    Yamamoto, N.3
  • 60
    • 0023603320 scopus 로고
    • Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels
    • Pacini F, Lippi F, Formica N, Elisei R, Anelli S, Ceccarelli C et al. Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels. J Nucl Med 1987;28:1888-91.
    • (1987) J Nucl Med , vol.28 , pp. 1888-1891
    • Pacini, F.1    Lippi, F.2    Formica, N.3    Elisei, R.4    Anelli, S.5    Ceccarelli, C.6
  • 61
    • 0034454889 scopus 로고    scopus 로고
    • Embolization for vertebral metastases of follicular thyroid carcinoma
    • Smit JWA, Vielvoye GJ, Goslings BM. Embolization for vertebral metastases of follicular thyroid carcinoma. J Clin Endocrinol Metab 2000;85:989-94.
    • (2000) J Clin Endocrinol Metab , vol.85 , pp. 989-994
    • Smit, J.W.A.1    Vielvoye, G.J.2    Goslings, B.M.3
  • 62
    • 25444455379 scopus 로고    scopus 로고
    • Radiofrequency ablation therapy combined with cementoplasty for painful bone metastases: Initial experience
    • Toyota N, Naito A, Kakizawa H, Hieda M, Hirai N, Tachikake T et al. Radiofrequency ablation therapy combined with cementoplasty for painful bone metastases: initial experience. Cardiovasc Intervent Radiol 2005;28:578-83.
    • (2005) Cardiovasc Intervent Radiol , vol.28 , pp. 578-583
    • Toyota, N.1    Naito, A.2    Kakizawa, H.3    Hieda, M.4    Hirai, N.5    Tachikake, T.6
  • 63
    • 0035875234 scopus 로고    scopus 로고
    • Pamidronate improves the quality of life and induces clinical remission of bone metastases in patients with thyroid cancer
    • Vitale G, Fonderico F, Martignetti A, Caraglia M, Ciccarelli A, Nuzzo V et al. Pamidronate improves the quality of life and induces clinical remission of bone metastases in patients with thyroid cancer. Br J Cancer 2001;84:1586-90.
    • (2001) Br J Cancer , vol.84 , pp. 1586-1590
    • Vitale, G.1    Fonderico, F.2    Martignetti, A.3    Caraglia, M.4    Ciccarelli, A.5    Nuzzo, V.6
  • 65
    • 39049152497 scopus 로고    scopus 로고
    • The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer
    • Brown AP, Chen J, Hitchcock YJ, Szabo A, Shrieve DC, Tward JD. The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer. J Clin Endocrinol Metab. 2008;93:504-15
    • (2008) J Clin Endocrinol Metab , vol.93 , pp. 504-515
    • Brown, A.P.1    Chen, J.2    Hitchcock, Y.J.3    Szabo, A.4    Shrieve, D.C.5    Tward, J.D.6
  • 66
    • 79961002271 scopus 로고    scopus 로고
    • 131I in male patients with thyroid carcinoma
    • 131I in male patients with thyroid carcinoma. Arch Androl. 2005;51:171-5.
    • (2005) Arch Androl , vol.51 , pp. 171-175
    • Krassas, G.E.1    Pontikides, N.2
  • 67
    • 44149117258 scopus 로고    scopus 로고
    • Therapeutic Administration of 131I for Differentiated Thyroid Cancer: Radiation Dose to Ovaries and Outcome of Pregnancies
    • Garsi JP, Schlumberger M, Rubino C, Ricard M, Labbé M, Ceccarelli C et al. Therapeutic Administration of 131I for Differentiated Thyroid Cancer: Radiation Dose to Ovaries and Outcome of Pregnancies. J Nucl Med J Nucl Med 2008;49:845-52.
    • (2008) J Nucl Med J Nucl Med , vol.49 , pp. 845-852
    • Garsi, J.P.1    Schlumberger, M.2    Rubino, C.3    Ricard, M.4    Labbé, M.5    Ceccarelli, C.6
  • 68
    • 37649007270 scopus 로고    scopus 로고
    • CELL-DOSE: A Monte Carlo code to assess electron dose distribution - S values for 131I in spheres of various sizes
    • Champion C, Zanotti-Fregonara P, Hindié E. CELL-DOSE: a Monte Carlo code to assess electron dose distribution - S values for 131I in spheres of various sizes. J Nucl Med 2008;49:151-7.
    • (2008) J Nucl Med , vol.49 , pp. 151-157
    • Champion, C.1    Zanotti-Fregonara, P.2    Hindié, E.3
  • 69
    • 0022355480 scopus 로고
    • A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma
    • Shimaoka K, Schoenfeld DA, DeWys WD, Creech RH, DeConti R. A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma. Cancer 1985;56:2155-60.
    • (1985) Cancer , vol.56 , pp. 2155-2160
    • Shimaoka, K.1    Schoenfeld, D.A.2    DeWys, W.D.3    Creech, R.H.4    DeConti, R.5
  • 71
    • 0036739992 scopus 로고    scopus 로고
    • Cytotoxic effects of carboplatinum and epirubicin in the setting of an elevated serum thyrotropin for advanced poorly differentiated thyroid cancer
    • Santini F, Bottici V, Elisei R, Montanelli L, Mazzeo S, Basolo F et al. Cytotoxic effects of carboplatinum and epirubicin in the setting of an elevated serum thyrotropin for advanced poorly differentiated thyroid cancer. J Clin Endocrinol Metab 2002;87:4160-5.
    • (2002) J Clin Endocrinol Metab , vol.87 , pp. 4160-4165
    • Santini, F.1    Bottici, V.2    Elisei, R.3    Montanelli, L.4    Mazzeo, S.5    Basolo, F.6
  • 72
    • 0038605690 scopus 로고    scopus 로고
    • In-111 DTPA-octreotide scintigraphy for disease detection in metastatic thyroid cancer: Comparison with F-18 FDG positron emission tomography and extensive conventional radiographic imaging
    • Sarlis NJ, Gourgiotis L, Guthrie LC, Galen B, Skarulis MC, Shawker TH et al. In-111 DTPA-octreotide scintigraphy for disease detection in metastatic thyroid cancer: comparison with F-18 FDG positron emission tomography and extensive conventional radiographic imaging. Clin Nucl Med 2003;28:208-17.
    • (2003) Clin Nucl Med , vol.28 , pp. 208-217
    • Sarlis, N.J.1    Gourgiotis, L.2    Guthrie, L.C.3    Galen, B.4    Skarulis, M.C.5    Shawker, T.H.6
  • 73
    • 14844359800 scopus 로고    scopus 로고
    • Peptide receptor radionuclide therapy for non-radioiodine-avid differentiated thyroid carcinoma
    • Teunissen JJ, Kwekkeboom DJ, Kooij PP, Bakker WH, Krenning EP. Peptide receptor radionuclide therapy for non-radioiodine-avid differentiated thyroid carcinoma. J Nucl Med 2005;46(Suppl 1):107S-14S.
    • (2005) J Nucl Med , vol.46 , Issue.SUPPL. 1
    • Teunissen, J.J.1    Kwekkeboom, D.J.2    Kooij, P.P.3    Bakker, W.H.4    Krenning, E.P.5
  • 75
    • 33646832056 scopus 로고    scopus 로고
    • Lithium as adjuvant to radioiodine therapy in differentiated thyroid carcinoma: Clinical and in vitro studies
    • Oxf
    • Liu YY, van der Pluijm G, Karperien M, Stokkel MP, Pereira AM, Morreau J et al. Lithium as adjuvant to radioiodine therapy in differentiated thyroid carcinoma: clinical and in vitro studies. Clin Endocrinol (Oxf) 2006;64:617-24.
    • (2006) Clin Endocrinol , vol.64 , pp. 617-624
    • Liu, Y.Y.1    Van Der Pluijm, G.2    Karperien, M.3    Stokkel, M.P.4    Pereira, A.M.5    Morreau, J.6
  • 76
    • 0031800394 scopus 로고    scopus 로고
    • Functional retinoid and thyroid hormone receptors in human thyroid-carcinoma cell lines and tissues
    • Schmutzler C, Brtko J, Winzer R, Jakobs TC, Meissner-Weigl J, Simon D et al. Functional retinoid and thyroid hormone receptors in human thyroid-carcinoma cell lines and tissues. Int J Cancer 1998;76:368-76.
    • (1998) Int J Cancer , vol.76 , pp. 368-376
    • Schmutzler, C.1    Brtko, J.2    Winzer, R.3    Jakobs, T.C.4    Meissner-Weigl, J.5    Simon, D.6
  • 77
    • 0034456589 scopus 로고    scopus 로고
    • All-trans-retinoic acid modulates expression levels of thyroglobulin and cytokines in a new human poorly differentiated papillary thyroid carcinoma cell line, KTC-1
    • Kurebayashi J, Tanaka K, Otsuki T, Moriya T, Kunisue H, Uno M et al. All-trans-retinoic acid modulates expression levels of thyroglobulin and cytokines in a new human poorly differentiated papillary thyroid carcinoma cell line, KTC-1. J Clin Endocrinol Metab 2000;85:2889-96.
    • (2000) J Clin Endocrinol Metab , vol.85 , pp. 2889-2896
    • Kurebayashi, J.1    Tanaka, K.2    Otsuki, T.3    Moriya, T.4    Kunisue, H.5    Uno, M.6
  • 79
  • 80
    • 0036597118 scopus 로고    scopus 로고
    • Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer: Final results of a pilot study
    • Simon D, Körber C, Krausch M, Segering J, Groth P, Görges R et al. Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer: final results of a pilot study. Eur J Nucl Med Mol Imaging 2002;29:775-82.
    • (2002) Eur J Nucl Med Mol Imaging , vol.29 , pp. 775-782
    • Simon, D.1    Körber, C.2    Krausch, M.3    Segering, J.4    Groth, P.5    Görges, R.6
  • 82
    • 33846459070 scopus 로고    scopus 로고
    • Defective efficacy of retinoic acid treatment in patients with metastatic thyroid carcinoma
    • Courbon F, Zerdoud S, Bastie D, Archambaud F, Hoff M, Eche N et al. Defective efficacy of retinoic acid treatment in patients with metastatic thyroid carcinoma. Thyroid 2006;16:1025-31.
    • (2006) Thyroid , vol.16 , pp. 1025-1031
    • Courbon, F.1    Zerdoud, S.2    Bastie, D.3    Archambaud, F.4    Hoff, M.5    Eche, N.6
  • 83
    • 40749092848 scopus 로고    scopus 로고
    • Radioiodine therapy after pretreatment with bexarotene for metastases of differentiated thyroid carcinoma
    • Oxf
    • Liu YY, Stokkel MP, Morreau HA, Pereira AM, Romijn JA, Smit JW. Radioiodine therapy after pretreatment with bexarotene for metastases of differentiated thyroid carcinoma. Clin Endocrinol (Oxf) 2008;68:605-9.
    • (2008) Clin Endocrinol , vol.68 , pp. 605-609
    • Liu, Y.Y.1    Stokkel, M.P.2    Morreau, H.A.3    Pereira, A.M.4    Romijn, J.A.5    Smit, J.W.6
  • 84
    • 34247620449 scopus 로고    scopus 로고
    • A clinical study of all-trans-retinoid-induced differentiation therapy of advanced thyroid cancer
    • Zhang Y, Jia S, Liu Y, Li B, Wang Z, Lu H et al. A clinical study of all-trans-retinoid-induced differentiation therapy of advanced thyroid cancer. Nucl Med Commun 2007;28:251-5.
    • (2007) Nucl Med Commun , vol.28 , pp. 251-255
    • Zhang, Y.1    Jia, S.2    Liu, Y.3    Li, B.4    Wang, Z.5    Lu, H.6
  • 85
    • 34249977889 scopus 로고    scopus 로고
    • Epigenetic patterns of the retinoic acid receptor beta2 promoter in retinoic acid-resistant thyroid cancer cells
    • Cras A, Darsin-Bettinger D, Balitrand N, Cassinat B, Soulie A, Toubert ME et al. Epigenetic patterns of the retinoic acid receptor beta2 promoter in retinoic acid-resistant thyroid cancer cells. Oncogene 2007;26:4018-24.
    • (2007) Oncogene , vol.26 , pp. 4018-4024
    • Cras, A.1    Darsin-Bettinger, D.2    Balitrand, N.3    Cassinat, B.4    Soulie, A.5    Toubert, M.E.6
  • 86
    • 39149083748 scopus 로고    scopus 로고
    • New insights in thyroid follicular cell biology and its impact in thyroid cancer therapy
    • Riesco-Eizaguirre G, Santisteban P. New insights in thyroid follicular cell biology and its impact in thyroid cancer therapy. Endocr Relat Cancer 2007;14:957-77.
    • (2007) Endocr Relat Cancer , vol.14 , pp. 957-977
    • Riesco-Eizaguirre, G.1    Santisteban, P.2
  • 87
    • 22044442973 scopus 로고    scopus 로고
    • Tyrosine kinases as targets for cancer therapy
    • Krause DS, Van Etten RA. Tyrosine kinases as targets for cancer therapy. N Engl J Med 2005;353:172-87.
    • (2005) N Engl J Med , vol.353 , pp. 172-187
    • Krause, D.S.1    Van Etten, R.A.2
  • 88
    • 9444277283 scopus 로고    scopus 로고
    • How thyroid tumors start and why it matters: Kinase mutants as targets for solid cancer pharmacotherapy
    • Fagin JA How thyroid tumors start and why it matters: kinase mutants as targets for solid cancer pharmacotherapy. J Endocrinol 2004;183:249-56.
    • (2004) J Endocrinol , vol.183 , pp. 249-256
    • Fagin, J.A.1
  • 91
    • 40949118479 scopus 로고    scopus 로고
    • Where Do We Stand with Targeted Therapy of Refractory Thyroid Cancer?-Utility of RECIST Criteria
    • Pacini F. Where Do We Stand with Targeted Therapy of Refractory Thyroid Cancer?-Utility of RECIST Criteria. Thyroid 2008;18:279-80.
    • (2008) Thyroid , vol.18 , pp. 279-280
    • Pacini, F.1
  • 92
    • 40549102299 scopus 로고    scopus 로고
    • Initial results from a phase II trial of motesanib diphosphate (AMG 706) in patients with differentiated thyroid cancer (DTC)
    • Sherman I, Schlumberger MJ, Droz J, Hoffmann M, Wirth L, Bastholt L et al. Initial results from a phase II trial of motesanib diphosphate (AMG 706) in patients with differentiated thyroid cancer (DTC). 2007 ASCO Annual Meeting Proceedings Part I. Vol. 25, No. 18S (June 20 Supplement), 2007:6017.
    • (2007) 2007 ASCO Annual Meeting Proceedings Part I , vol.25 , Issue.18 S JUNE 20 SUPPL. , pp. 6017
    • Sherman, I.1    Schlumberger, M.J.2    Droz, J.3    Hoffmann, M.4    Wirth, L.5    Bastholt, L.6
  • 93
    • 33749259546 scopus 로고    scopus 로고
    • Significant clinical and biologic activity of RAF/VEGF-R kinase inhibitor BAY 43-9006 in patients with metastatic papillary thyroid carcinoma (PTC): Updated results of a phase II study
    • Post-Meeting Edition
    • Kloos R, Ringel M, Knopp M, Heverhagen J, Rittenberry J, Weldy L et al. Significant clinical and biologic activity of RAF/VEGF-R kinase inhibitor BAY 43-9006 in patients with metastatic papillary thyroid carcinoma (PTC): Updated results of a phase II study. 2006 ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol. 24, No. 18S (June 20 Supplement), 2006:5534.
    • (2006) 2006 ASCO Annual Meeting Proceedings , vol.24 , Issue.18 S JUNE 20 SUPPL. , pp. 5534
    • Kloos, R.1    Ringel, M.2    Knopp, M.3    Heverhagen, J.4    Rittenberry, J.5    Weldy, L.6
  • 96
    • 34548189195 scopus 로고    scopus 로고
    • Phase II trial of thalidomide for therapy of radioiodine-unresponsive and rapidly progressive thyroid carcinomas
    • Ain KB, Lee C, Williams KD. Phase II trial of thalidomide for therapy of radioiodine-unresponsive and rapidly progressive thyroid carcinomas. Thyroid 2007;17:663-70.
    • (2007) Thyroid , vol.17 , pp. 663-670
    • Ain, K.B.1    Lee, C.2    Williams, K.D.3
  • 98
    • 29244454573 scopus 로고    scopus 로고
    • Radiation combined with antiangiogenic and antivascular agents
    • O'Reilly MS. Radiation combined with antiangiogenic and antivascular agents. Semin Radiat Oncol 2006;16:45-50.
    • (2006) Semin Radiat Oncol , vol.16 , pp. 45-50
    • O'Reilly, M.S.1
  • 99


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.